Other Solid Tumors in China
Overview
This program covers the full range of solid tumors beyond the major site-specific programs — including kidney, bladder, esophageal, thyroid, head-and-neck and other cancers — each treated by dedicated multidisciplinary teams.
China’s national cancer network offers site-specific surgical teams, precision radiotherapy and access to domestically developed targeted and immune oncology drugs alongside international agents.
Symptoms & Signs
Symptoms depend on the organ involved: blood in urine (bladder, kidney), difficulty swallowing (esophagus), neck lumps (thyroid)
Unexplained weight loss, night sweats or persistent fatigue common across advanced cancers
New, persistent pain in any body region that does not resolve
A noticeable or palpable mass anywhere on the body
Changes in bowel or bladder function lasting weeks
Chronic cough or hoarseness beyond three weeks
Diagnosis
Organ-focused imaging: ultrasound, contrast CT or MRI as first-line
Endoscopy for luminal cancers (esophagus, stomach, colon, bladder)
Image-guided core needle biopsy establishing tissue diagnosis
Molecular profiling (NGS) identifying actionable mutations
PET-CT for whole-body staging and response assessment
Tumor markers where clinically informative for monitoring
Treatment Options
Site-specific oncologic surgery by dedicated surgical teams
Minimally invasive laparoscopic and robotic approaches where appropriate
Precision radiotherapy: IMRT, VMAT and SBRT for local control
Systemic chemotherapy tailored to tumor type and patient fitness
Targeted therapy and immunotherapy for actionable molecular profiles
Multidisciplinary tumor-board review individualizing every treatment plan
Advanced Technologies & Novel Drug
da Vinci surgical platforms across urologic, thoracic and abdominal cancers
Next-generation sequencing informing targeted drug selection
Advanced radiotherapy with online adaptive planning
Interventional oncology: TACE, ablation and portal-vein embolization
Novel antibody-drug conjugates and immunotherapy combinations available at major centers
Hospital & Specialist
- Cancer Hospital, Chinese Academy of Medical Sciences (CICAMS) — Beijing
- Sun Yat-sen University Cancer Center (SYSUCC) — Guangzhou
- Fudan University Shanghai Cancer Center (FUSCC) — Shanghai
- Tianjin Medical University Cancer Institute and Hospital (TMUCIH) — Tianjin
- Li Jun Ling — Medical Oncology
- Wang Xing Yuan — Medical Oncology
- Zhang Xiao Shi — Medical Oncology
- Lin Tong Yu — Medical Oncology